Overview
Integrated technology platform for clinical research AI, data management, trial operations, and endpoint assessment
Funding
USD estimates from the source recordListed 2 funding records. Latest funding: $714K (股权投资), Aug 18, 2025.
Annual trendUnit: USD estimate
| Date | Amount | Investors | Source |
|---|---|---|---|
| Aug 18, 2025 | $714K | Tongshang Group | |
| Mar 19, 2025 | $1.4M | Hongfeng Investment |
Valuation
USD estimates from the source recordListed 2 valuation records.
Annual trendUnit: USD estimate
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Source |
|---|---|---|---|
| Aug 18, 2025 | — | Tongshang Group | |
| Mar 19, 2025 | — | Hongfeng Investment |
Revenue
USD estimates from the source recordNo revenue records are listed yet.
Annual trendUnit: USD estimate
No chartable revenue estimates yet.
No revenue rows to list.
Team, products & investors
Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
临床研究AI与数据管理、试验运营及终点评估一体化技术平台